• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TET1:临床疾病进展的表观遗传构建者。

TET1: The epigenetic architect of clinical disease progression.

作者信息

Jabbari Keyvan, Khalafizadeh Ali, Sheikhbahaei Mahboubeh, Soltaninejad Hossein, Babashah Sadegh

机构信息

Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran 14115-154, Iran.

Department of Stem Cells Technology and Tissue Regeneration, Faculty of Interdisciplinary Sciences and Technologies, Tarbiat Modares University, Tehran 14115-154, Iran.

出版信息

Genes Dis. 2025 Jan 4;12(5):101513. doi: 10.1016/j.gendis.2025.101513. eCollection 2025 Sep.

DOI:10.1016/j.gendis.2025.101513
PMID:40520993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12167460/
Abstract

The ten-eleven translocation 1 (TET1) protein, a member of the human α-ketoglutarate-dependent dioxygenase TET family, functions as a 5-methylcytosine hydroxylase with a strong affinity for genomic regions enriched with 5'-CpG-3' dinucleotides, particularly CpG islands. TET1 is critical in initiating DNA demethylation and maintaining a balanced interaction between demethylation and DNA methylation, which is essential for genomic methylation stability and precise epigenetic regulation. By removing methyl groups from specific tumor suppressor genes, TET1 can influence their expression. This review summarizes the latest advancements in TET1 research, emphasizing its role in demethylation mechanisms and its significance in regulatory processes related to clinical conditions. TET1 is a crucial mediator of demethylation, although the precise details of this mechanism are not yet fully understood. Additionally, TET1 plays a key role in inhibiting tumor progression, but its effects vary across different tumors. This variability arises from its interactions with diverse signaling pathways, where it can function either as an antagonist or a promoter. The role of TET1 remains controversial in certain cancer types, and its potential oncogenic functions have attracted growing interest, opening new avenues for investigation.

摘要

10-11易位蛋白1(TET1)是人类α-酮戊二酸依赖性双加氧酶TET家族的成员,作为一种5-甲基胞嘧啶羟化酶,对富含5'-CpG-3'二核苷酸的基因组区域,特别是CpG岛具有很强的亲和力。TET1在启动DNA去甲基化以及维持去甲基化与DNA甲基化之间的平衡相互作用方面至关重要,这对于基因组甲基化稳定性和精确的表观遗传调控必不可少。通过从特定的肿瘤抑制基因上去除甲基基团,TET1可以影响它们的表达。本综述总结了TET1研究的最新进展,强调了其在去甲基化机制中的作用及其在与临床病症相关的调控过程中的意义。TET1是去甲基化的关键介质,尽管该机制的确切细节尚未完全了解。此外,TET1在抑制肿瘤进展中起关键作用,但其作用在不同肿瘤中有所不同。这种变异性源于其与多种信号通路的相互作用,在这些信号通路中它既可以作为拮抗剂也可以作为促进剂发挥作用。TET1在某些癌症类型中的作用仍存在争议,其潜在的致癌功能已引起越来越多的关注,为研究开辟了新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873d/12167460/68413acb672a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873d/12167460/8a2f3f8a0ada/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873d/12167460/eee53d4323ba/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873d/12167460/20c2b3134afb/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873d/12167460/68413acb672a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873d/12167460/8a2f3f8a0ada/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873d/12167460/eee53d4323ba/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873d/12167460/20c2b3134afb/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873d/12167460/68413acb672a/gr4.jpg

相似文献

1
TET1: The epigenetic architect of clinical disease progression.TET1:临床疾病进展的表观遗传构建者。
Genes Dis. 2025 Jan 4;12(5):101513. doi: 10.1016/j.gendis.2025.101513. eCollection 2025 Sep.
2
Advances in the DNA methylation hydroxylase TET1.DNA甲基化羟化酶TET1的研究进展
Biomark Res. 2021 Oct 16;9(1):76. doi: 10.1186/s40364-021-00331-7.
3
[Advances in epigenetic regulation of the dioxygenase TET1].[双加氧酶TET1的表观遗传调控研究进展]
Sheng Wu Gong Cheng Xue Bao. 2024 Dec 25;40(12):4351-4364. doi: 10.13345/j.cjb.240191.
4
Tet methylcytosine dioxygenase 1 promotes hypoxic gene induction and cell migration in colon cancer.Tet 甲基胞嘧啶双加氧酶 1 促进结肠癌缺氧基因诱导和细胞迁移。
J Cell Physiol. 2019 May;234(5):6286-6297. doi: 10.1002/jcp.27359. Epub 2018 Oct 26.
5
Targeted TET oxidase activity through methyl-CpG-binding domain extensively suppresses cancer cell proliferation.通过甲基化CpG结合结构域靶向TET氧化酶活性可广泛抑制癌细胞增殖。
Cancer Med. 2016 Sep;5(9):2522-33. doi: 10.1002/cam4.830. Epub 2016 Jul 25.
6
5-hydroxymethylcytosines regulate gene expression as a passive DNA demethylation resisting epigenetic mark in proliferative somatic cells.5-羟甲基胞嘧啶作为一种抵抗表观遗传标记的被动DNA去甲基化方式,在增殖性体细胞中调节基因表达。
bioRxiv. 2023 Sep 27:2023.09.26.559662. doi: 10.1101/2023.09.26.559662.
7
Tet1-dependent epigenetic modification of BDNF expression in dorsal horn neurons mediates neuropathic pain in rats.Tet1 依赖性脑源性神经营养因子表达的表观遗传修饰介导大鼠背角神经元的神经病理性疼痛。
Sci Rep. 2016 Nov 18;6:37411. doi: 10.1038/srep37411.
8
Ten-eleven translocation 1 (TET1) gene is a potential target of miR-21-5p in human colorectal cancer.十一易位蛋白1(TET1)基因是人类结直肠癌中miR-21-5p的潜在靶点。
Surg Oncol. 2018 Mar;27(1):76-81. doi: 10.1016/j.suronc.2017.12.004. Epub 2018 Jan 3.
9
TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.TET1通过PTEN去甲基化和重新表达来抑制胃癌的生长和转移。
Oncotarget. 2016 May 24;7(21):31322-35. doi: 10.18632/oncotarget.8900.
10
Novel Epigenetic Controlling of Hypoxia Pathway Related to Overexpression and Promoter Hypomethylation of TET1 and TET2 in RPE Cells.视网膜色素上皮细胞中与TET1和TET2过表达及启动子低甲基化相关的缺氧途径的新型表观遗传调控
J Cell Biochem. 2017 Oct;118(10):3193-3204. doi: 10.1002/jcb.25965. Epub 2017 Apr 12.

引用本文的文献

1
Polarization of Tumor Cells and Tumor-Associated Macrophages: Molecular Mechanisms and Therapeutic Targets.肿瘤细胞与肿瘤相关巨噬细胞的极化:分子机制与治疗靶点
MedComm (2020). 2025 Sep 1;6(9):e70372. doi: 10.1002/mco2.70372. eCollection 2025 Sep.

本文引用的文献

1
TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy.TET1通过调节自噬来抑制宫颈癌细胞的迁移和侵袭。
Epigenetics. 2024 Dec;19(1):2323751. doi: 10.1080/15592294.2024.2323751. Epub 2024 Mar 3.
2
miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2.微小RNA-543通过靶向TET1和TET2调控骨髓纤维化的表观遗传格局。
JCI Insight. 2024 Feb 8;9(3):e178762. doi: 10.1172/jci.insight.178762.
3
Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins.
开发新型表观遗传抗癌疗法靶向 TET 蛋白。
Int J Mol Sci. 2023 Nov 15;24(22):16375. doi: 10.3390/ijms242216375.
4
Direct inhibition of dioxygenases TET1 by the rheumatoid arthritis drug auranofin selectively induces cancer cell death in T-ALL.类风湿关节炎药物金诺芬选择性地直接抑制双加氧酶 TET1,从而诱导 T-ALL 中的癌细胞死亡。
J Hematol Oncol. 2023 Nov 22;16(1):113. doi: 10.1186/s13045-023-01513-6.
5
TET protein inhibitors: Potential and limitations.TET 蛋白抑制剂:潜力与局限性。
Biomed Pharmacother. 2023 Oct;166:115324. doi: 10.1016/j.biopha.2023.115324. Epub 2023 Aug 18.
6
TET (Ten-eleven translocation) family proteins: structure, biological functions and applications.TET(Ten-eleven translocation)家族蛋白:结构、生物学功能及应用。
Signal Transduct Target Ther. 2023 Aug 11;8(1):297. doi: 10.1038/s41392-023-01537-x.
7
Role of TET1-mediated epigenetic modulation in Alzheimer's disease.TET1 介导的表观遗传调控在阿尔茨海默病中的作用。
Neurobiol Dis. 2023 Sep;185:106257. doi: 10.1016/j.nbd.2023.106257. Epub 2023 Aug 8.
8
High Expression of Ten Eleven Translocation 1 Is Associated with Poor Prognosis in Hepatocellular Carcinoma.Ten Eleven Translocation 1 高表达与肝细胞癌预后不良相关。
Mediators Inflamm. 2023 May 4;2023:2664370. doi: 10.1155/2023/2664370. eCollection 2023.
9
Hypoxia switches TET1 from being tumor-suppressive to oncogenic.缺氧将 TET1 从抑瘤基因转变为致癌基因。
Oncogene. 2023 May;42(20):1634-1648. doi: 10.1038/s41388-023-02659-w. Epub 2023 Apr 5.
10
Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia.磷酸化稳定的 TET1 作为 B 细胞急性淋巴细胞白血病的癌蛋白和治疗靶点。
Sci Transl Med. 2023 Mar 29;15(689):eabq8513. doi: 10.1126/scitranslmed.abq8513.